Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Proc Natl Acad Sci U S A ; 115(4): E753-E761, 2018 01 23.
Artículo en Inglés | MEDLINE | ID: mdl-29317534

RESUMEN

The fungal genus of Aspergillus is highly interesting, containing everything from industrial cell factories, model organisms, and human pathogens. In particular, this group has a prolific production of bioactive secondary metabolites (SMs). In this work, four diverse Aspergillus species (A. campestris, A. novofumigatus, A. ochraceoroseus, and A. steynii) have been whole-genome PacBio sequenced to provide genetic references in three Aspergillus sections. A. taichungensis and A. candidus also were sequenced for SM elucidation. Thirteen Aspergillus genomes were analyzed with comparative genomics to determine phylogeny and genetic diversity, showing that each presented genome contains 15-27% genes not found in other sequenced Aspergilli. In particular, A. novofumigatus was compared with the pathogenic species A. fumigatus This suggests that A. novofumigatus can produce most of the same allergens, virulence, and pathogenicity factors as A. fumigatus, suggesting that A. novofumigatus could be as pathogenic as A. fumigatus Furthermore, SMs were linked to gene clusters based on biological and chemical knowledge and analysis, genome sequences, and predictive algorithms. We thus identify putative SM clusters for aflatoxin, chlorflavonin, and ochrindol in A. ochraceoroseus, A. campestris, and A. steynii, respectively, and novofumigatonin, ent-cycloechinulin, and epi-aszonalenins in A. novofumigatus Our study delivers six fungal genomes, showing the large diversity found in the Aspergillus genus; highlights the potential for discovery of beneficial or harmful SMs; and supports reports of A. novofumigatus pathogenicity. It also shows how biological, biochemical, and genomic information can be combined to identify genes involved in the biosynthesis of specific SMs.


Asunto(s)
Aflatoxinas/genética , Aspergillus/genética , Aspergillus/metabolismo , Familia de Multigenes , Metabolismo Secundario/genética , Aflatoxinas/biosíntesis , Alérgenos/genética , Aspergillus/patogenicidad , Metilación de ADN , Evolución Molecular , Flavonoides/biosíntesis , Genoma Fúngico , Alcaloides Indólicos/metabolismo , Filogenia , Terpenos/metabolismo , Secuenciación Completa del Genoma
2.
Fungal Genet Biol ; 115: 78-89, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29325827

RESUMEN

CRISPR-Cas9 technologies are revolutionizing fungal gene editing. Here we show that survival of specific Cas9/sgRNA mediated DNA double strand breaks (DSBs) depends on the non-homologous end-joining, NHEJ, DNA repair pathway and we use this observation to develop a tool, TAPE, to assess protospacer efficiency in Aspergillus nidulans. Moreover, we show that in NHEJ deficient strains, highly efficient marker-free gene targeting can be performed. Indeed, we show that even single-stranded oligo nucleotides efficiently work as repair templates of specific Cas9/sgRNA induced DNA DSBs in A. nidulans, A. niger, and in A. oryzae indicating that this type of repair may be wide-spread in filamentous fungi. Importantly, we demonstrate that by using single-stranded oligo nucleotides for CRISPR-Cas9 mediated gene editing it is possible to introduce specific point mutations as well gene deletions at efficiencies approaching 100%. The efficiency of the system invites for multiplexing and we have designed a vector system with the capacity of delivering Cas9 and multiple sgRNAs based on polymerase III promoters and tRNA spacers. We show that it is possible to introduce two point mutations and one gene insertion in one transformation experiment with a very high efficiency. Our system is compatible with future high-throughput gene-editing experiments.


Asunto(s)
Aspergillus/genética , Sistemas CRISPR-Cas/genética , Roturas del ADN de Doble Cadena , Edición Génica/métodos , Eliminación de Gen , Marcación de Gen , Vectores Genéticos , Oligonucleótidos/genética , ARN de Transferencia/genética
3.
Nat Commun ; 11(1): 1106, 2020 02 27.
Artículo en Inglés | MEDLINE | ID: mdl-32107379

RESUMEN

Section Flavi encompasses both harmful and beneficial Aspergillus species, such as Aspergillus oryzae, used in food fermentation and enzyme production, and Aspergillus flavus, food spoiler and mycotoxin producer. Here, we sequence 19 genomes spanning section Flavi and compare 31 fungal genomes including 23 Flavi species. We reassess their phylogenetic relationships and show that the closest relative of A. oryzae is not A. flavus, but A. minisclerotigenes or A. aflatoxiformans and identify high genome diversity, especially in sub-telomeric regions. We predict abundant CAZymes (598 per species) and prolific secondary metabolite gene clusters (73 per species) in section Flavi. However, the observed phenotypes (growth characteristics, polysaccharide degradation) do not necessarily correlate with inferences made from the predicted CAZyme content. Our work, including genomic analyses, phenotypic assays, and identification of secondary metabolites, highlights the genetic and metabolic diversity within section Flavi.


Asunto(s)
Aspergillus flavus/genética , Aspergillus oryzae/genética , Genoma Fúngico/genética , Genómica , Aspergillus flavus/clasificación , Aspergillus flavus/enzimología , Aspergillus oryzae/clasificación , Aspergillus oryzae/enzimología , Reactores Biológicos , Metabolismo de los Hidratos de Carbono/genética , Productos Agrícolas/microbiología , ADN de Hongos/genética , Fermentación , Alimentos Fermentados , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Redes y Vías Metabólicas/genética , Familia de Multigenes , Fenotipo , Filogenia , Enfermedades de las Plantas/prevención & control , Metabolismo Secundario/genética
4.
Nat Genet ; 50(12): 1688-1695, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-30349117

RESUMEN

Aspergillus section Nigri comprises filamentous fungi relevant to biomedicine, bioenergy, health, and biotechnology. To learn more about what genetically sets these species apart, as well as about potential applications in biotechnology and biomedicine, we sequenced 23 genomes de novo, forming a full genome compendium for the section (26 species), as well as 6 Aspergillus niger isolates. This allowed us to quantify both inter- and intraspecies genomic variation. We further predicted 17,903 carbohydrate-active enzymes and 2,717 secondary metabolite gene clusters, which we condensed into 455 distinct families corresponding to compound classes, 49% of which are only found in single species. We performed metabolomics and genetic engineering to correlate genotypes to phenotypes, as demonstrated for the metabolite aurasperone, and by heterologous transfer of citrate production to Aspergillus nidulans. Experimental and computational analyses showed that both secondary metabolism and regulation are key factors that are significant in the delineation of Aspergillus species.


Asunto(s)
Aspergillus/genética , Especiación Genética , Variación Genética , Genoma Fúngico , Aspergillus/clasificación , Aspergillus/metabolismo , Secuencia de Bases , Metabolismo de los Hidratos de Carbono/genética , Genoma Fúngico/genética , Familia de Multigenes , Filogenia , Especificidad de la Especie , Secuenciación Completa del Genoma
5.
PLoS One ; 10(7): e0133085, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26177455

RESUMEN

The number of fully sequenced fungal genomes is rapidly increasing. Since genetic tools are poorly developed for most filamentous fungi, it is currently difficult to employ genetic engineering for understanding the biology of these fungi and to fully exploit them industrially. For that reason there is a demand for developing versatile methods that can be used to genetically manipulate non-model filamentous fungi. To facilitate this, we have developed a CRISPR-Cas9 based system adapted for use in filamentous fungi. The system is simple and versatile, as RNA guided mutagenesis can be achieved by transforming a target fungus with a single plasmid. The system currently contains four CRISPR-Cas9 vectors, which are equipped with commonly used fungal markers allowing for selection in a broad range of fungi. Moreover, we have developed a script that allows identification of protospacers that target gene homologs in multiple species to facilitate introduction of common mutations in different filamentous fungi. With these tools we have performed RNA-guided mutagenesis in six species of which one has not previously been genetically engineered. Moreover, for a wild-type Aspergillus aculeatus strain, we have used our CRISPR Cas9 system to generate a strain that contains an AACU_pyrG marker and demonstrated that the resulting strain can be used for iterative gene targeting.


Asunto(s)
Aspergillus/genética , Sistemas CRISPR-Cas , Regulación Fúngica de la Expresión Génica , Marcación de Gen/métodos , Ingeniería Genética/métodos , Plásmidos/química , Aspergillus/clasificación , Aspergillus/metabolismo , Secuencia de Bases , Escherichia coli/genética , Escherichia coli/metabolismo , Marcadores Genéticos , Datos de Secuencia Molecular , Mutagénesis , Plásmidos/metabolismo , ARN Catalítico/genética , ARN Catalítico/metabolismo , ARN Guía de Kinetoplastida/genética , ARN Guía de Kinetoplastida/metabolismo , Transformación Genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA